121 related articles for article (PubMed ID: 34242401)
1. Targeted sequencing of localized acral melanoma in Korean patients identified recurrent CCND1 amplification.
Kim YS; Jung SH; Chung YJ; Lee JH
Int J Dermatol; 2022 Feb; 61(2):e61-e63. PubMed ID: 34242401
[No Abstract] [Full Text] [Related]
2. CCND1 copy number increase and cyclin D1 expression in acral melanoma: a comparative study of fluorescence in situ hybridization and immunohistochemistry in a Chinese cohort.
Liu J; Yu W; Gao F; Qi S; Du J; Ma X; Zhang Y; Zheng J; Su J
Diagn Pathol; 2021 Jul; 16(1):60. PubMed ID: 34225728
[TBL] [Abstract][Full Text] [Related]
3. Genetic Alterations in Primary Acral Melanoma and Acral Melanocytic Nevus in Korea: Common Mutated Genes Show Distinct Cytomorphological Features.
Moon KR; Choi YD; Kim JM; Jin S; Shin MH; Shim HJ; Lee JB; Yun SJ
J Invest Dermatol; 2018 Apr; 138(4):933-945. PubMed ID: 29191620
[TBL] [Abstract][Full Text] [Related]
4. An update on the implications of cyclin D1 in melanomas.
González-Ruiz L; González-Moles MÁ; González-Ruiz I; Ruiz-Ávila I; Ayén Á; Ramos-García P
Pigment Cell Melanoma Res; 2020 Nov; 33(6):788-805. PubMed ID: 32147907
[TBL] [Abstract][Full Text] [Related]
5. The role of CCND1 alterations during the progression of cutaneous malignant melanoma.
Vízkeleti L; Ecsedi S; Rákosy Z; Orosz A; Lázár V; Emri G; Koroknai V; Kiss T; Ádány R; Balázs M
Tumour Biol; 2012 Dec; 33(6):2189-99. PubMed ID: 23001925
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic signaling pathways and hallmarks of cancer in Korean patients with acral melanoma.
Moon S; Kim HJ; Lee Y; Lee YJ; Jung S; Lee JS; Hahn SH; Kim K; Roh JY; Nam S
Comput Biol Med; 2023 Mar; 154():106602. PubMed ID: 36716688
[TBL] [Abstract][Full Text] [Related]
7. Malignant melanoma with monster cells showing massive cyclin D1 amplification.
Pouryazdanparast P; Newman M; Mafee M; Guitart J; Gerami P
Am J Dermatopathol; 2009 Jun; 31(4):402-3. PubMed ID: 19461251
[No Abstract] [Full Text] [Related]
8. Detecting copy number alterations of oncogenes in cell-free DNA to monitor treatment response in acral and mucosal melanoma.
Mikoshiba A; Ashida A; Sakaizawa K; Kiniwa Y; Okuyama R
J Dermatol Sci; 2020 Mar; 97(3):172-178. PubMed ID: 31987696
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic application of cyclin D1 fluorescent in situ hybridization for histologically undetermined early lesions of acral melanoma in situ: A case series.
Cho-Vega JH; Cao T; Ledon J; Moller M; Avisar E; Elgart G; Tan JH; Fan YS; Grichnik JM
Ann Diagn Pathol; 2021 Feb; 50():151681. PubMed ID: 33341705
[TBL] [Abstract][Full Text] [Related]
10. PD-L1 expression is regulated by microphthalmia-associated transcription factor (MITF) in nodular melanoma.
Vučinić D; Grahovac M; Grahovac B; Vitezić BM; Kovač L; Belušić-Gobić M; Zamolo G
Pathol Res Pract; 2022 Jan; 229():153725. PubMed ID: 34942512
[TBL] [Abstract][Full Text] [Related]
11. Cyclin D1 is a candidate oncogene in cutaneous melanoma.
Sauter ER; Yeo UC; von Stemm A; Zhu W; Litwin S; Tichansky DS; Pistritto G; Nesbit M; Pinkel D; Herlyn M; Bastian BC
Cancer Res; 2002 Jun; 62(11):3200-6. PubMed ID: 12036934
[TBL] [Abstract][Full Text] [Related]
12. Distinct sets of genetic alterations in melanoma.
Curtin JA; Fridlyand J; Kageshita T; Patel HN; Busam KJ; Kutzner H; Cho KH; Aiba S; Bröcker EB; LeBoit PE; Pinkel D; Bastian BC
N Engl J Med; 2005 Nov; 353(20):2135-47. PubMed ID: 16291983
[TBL] [Abstract][Full Text] [Related]
13. Whole-exome sequencing reveals differences between nail apparatus melanoma and acral melanoma.
Lee M; Yoon J; Chung YJ; Lee SY; Choi JY; Shin OR; Park HY; Bahk WJ; Yu DS; Lee YB
J Am Acad Dermatol; 2018 Sep; 79(3):559-561.e1. PubMed ID: 29438763
[No Abstract] [Full Text] [Related]
14. Specific dermoscopy patterns and amplifications of the cyclin D1 gene to define histopathologically unrecognizable early lesions of acral melanoma in situ.
Yamaura M; Takata M; Miyazaki A; Saida T
Arch Dermatol; 2005 Nov; 141(11):1413-8. PubMed ID: 16301388
[TBL] [Abstract][Full Text] [Related]
15. Homogeneous staining regions for cyclin D1, a marker of poor prognosis in malignant melanoma.
Gammon B; Ali L; Guitart J; Gerami P
Am J Dermatopathol; 2012 Jul; 34(5):487-90. PubMed ID: 22456513
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-365 Inhibits Cell Growth and Promotes Apoptosis in Melanoma by Targeting BCL2 and Cyclin D1 (CCND1).
Zhu Y; Wen X; Zhao P
Med Sci Monit; 2018 Jun; 24():3679-3692. PubMed ID: 29858490
[TBL] [Abstract][Full Text] [Related]
17. Lack of associations of selected variants in genes involved in cell cycle and apoptosis with skin cancer risk.
Han J; Colditz GA; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):592-3. PubMed ID: 16537723
[No Abstract] [Full Text] [Related]
18. Role of ROC1 protein in the control of cyclin D1 protein expression in skin melanomas.
Nai G; Marques M
Pathol Res Pract; 2011 Mar; 207(3):174-81. PubMed ID: 21300445
[TBL] [Abstract][Full Text] [Related]
19. Molecular pathogenesis of malignant melanoma: a different perspective from the studies of melanocytic nevus and acral melanoma.
Takata M; Murata H; Saida T
Pigment Cell Melanoma Res; 2010 Feb; 23(1):64-71. PubMed ID: 19788535
[TBL] [Abstract][Full Text] [Related]
20. Malignant Melanoma of the Nail Apparatus: A Fluorescence In Situ Hybridization Analysis of 7 Cases.
Romano RC; Shon W; Sukov WR
Int J Surg Pathol; 2016 Sep; 24(6):512-8. PubMed ID: 27185405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]